NCR Graphs - All Cancers

التصنيف العلاجي	الاسم	أساسي / جنيسي	التركيبة العلمية	العيار	الشكل الصيدلاني	سعر المبيع من العموم
L04AA52	KESIMPTA	BioTech	Ofatumumab - 20mg/0.4ml	20mg/0.4ml	Injectable solution	96,542,598 L.L
N07BC01	BUVIDAL	B	Buprenorphine - 8mg	8mg	Injectable solution prolonged release	8,524,771 L.L
N07BC01	BUVIDAL	B	Buprenorphine - 16mg	16mg	Injectable solution prolonged release	8,524,771 L.L
N07BC01	BUVIDAL	B	Buprenorphine - 24mg	24mg	Injectable solution prolonged release	8,524,771 L.L
N07BC01	BUVIDAL	B	Buprenorphine - 32mg	32mg	Injectable solution prolonged release	8,524,771 L.L
N07BC01	BUVIDAL	B	Buprenorphine - 64mg	64mg	Injectable solution prolonged release	34,835,645 L.L
N07BC01	BUVIDAL	B	Buprenorphine - 96mg	96mg	Injectable solution prolonged release	34,835,645 L.L
N07BC01	BUVIDAL	B	Buprenorphine - 128mg	128mg	Injectable solution prolonged release	34,835,645 L.L
J07BD52	M-M-R II (MEASLES, MUMPS AND RUBELLA VIRUS VACCINE LIVE)	B	Rubella virus live attenuated - , Mumps virus live attenuated - , Measles virus live attenuated -		Injectable solution+diluent	12,924,401 L.L
J01XA01	ZERMACIN	G	Vancomycin (HCl) - 0.5g	0.5g	Injectable sterile lyophilised powder for solution	840,861 L.L
J01XA01	ZERMACIN	G	Vancomycin (HCl) - 0.5g	0.5g	Injectable sterile lyophilised powder for solution	5,875,791 L.L
A02BC01	ULCAZAL	G	Omeprazole (sodium) - 40mg	40mg	Injectable sterile lyophilised powder for solution	895,895 L.L
A02BC01	ULCAZAL	G	Omeprazole (sodium) - 40mg	40mg	Injectable sterile lyophilised powder for solution	5,916,747 L.L
J01DH02	AROPEM	G	Meropenem - 0.5g	0.5g	Injectable sterile lyophilised powder for solution	995,723 L.L
J01DH02	AROPEM	G	Meropenem - 0.5g	0.5g	Injectable sterile lyophilised powder for solution	19,022,727 L.L
J01DH02	AROPEM	G	Meropenem - 1g	1g	Injectable sterile lyophilised powder for solution	995,723 L.L
J01DH02	AROPEM	G	Meropenem - 1g	1g	Injectable sterile lyophilised powder for solution	19,022,727 L.L
J01DD04	LEBACEF	G	Ceftriaxone - 1g	1g	Injectable sterile powder for solution + lidocaine solvent	508,100 L.L
J01DD04	LEBACEF	G	Ceftriaxone - 1g	1g	Injectable sterile powder for solution + lidocaine solvent	508,100 L.L
N02CD02	EMGALITY	BioTech	Galcanezumab - 120mg/ml	120mg/ml	Injectable suspension	37,250,732 L.L
H02AB01	DIPROFOS	B	Betamethasone (dipropionate) - 5mg/ml, Betamethasone (sodium phosphate) - 2mg/ml		Injectable suspension	446,156 L.L
L01BC07	AZACITIDINE ARROW	G	Azacitidine - 25mg/ml	25mg/ml	Injectable suspension	10,967,854 L.L
A10AB04	HUMALOG	BioTech	Insulin lispro - 100IU/ml	100IU/ml	Injectable suspension	1,988,887 L.L
A10AB04	PROLOG	BioTech	Insulin lispro - 100U/ml	100U/ml	Injectable suspension	1,503,312 L.L
A10AD01	HUMULIN 70/30	BioTech	Insulin (human) - 100IU/ml	100IU/ml	Injectable suspension	701,486 L.L
A10AD01	JUSLINE	BioTech	Insulin (human) - 100IU/ml	100IU/ml	Injectable suspension	401,809 L.L
A10AD01	MIXTARD 30	BioTech	Insulin (human) - 100IU/ml	100IU/ml	Injectable suspension	752,552 L.L
A10AD01	MIXTARD 30	BioTech	Insulin (human) - 100IU/ml	100IU/ml	Injectable suspension	752,552 L.L
A10AD04	HUMALOG MIX 50 KWIKPEN	BioTech	Insulin lispro solution - 50%, Insulin lispro protamine suspension - 50%	100IU/ml	Injectable suspension	3,950,897 L.L
A10AD04	HUMALOG MIX 25 KWIKPEN	BioTech	Insulin lispro solution - 25%, Insulin lispro protamine suspension - 75%	100IU/ml	Injectable suspension	3,950,897 L.L

رسومات بيانية لسجل الوطني للسرطان - نسب الحدوث حسب السنوات